Year: 2012
Type: letter
Abstract: medications suggesting a lack of consumer engagement and dissatisfaction with the treatments offered.The influence of all of these factors is magnified in the case of young people early in their experience of psychotic illness.Finally, the arbitrary threshold of sustained positive symptoms may be an imperfect guide to the timing of antipsychotic medication use in every patient.Some people with subthreshold psychosis (or attenuated psychotic symptoms) may fail to respond to psychosocial treatments as first line and prove to benefit from antipsychotic medications, while a subset of patients with first-episode psychosis with short durations of illness may not require antipsychotic medication.Our research and that of other groups has indicated that antipsychotic medications are not needed as first-line therapy in subthreshold psychosis.We are also attempting to clarify the timing and need for antipsychotic medication in first-episode psychosis by conducting a randomised controlled trial investigating whether intensive psychosocial treatment is sufficient for recovery in a selected low-risk subgroup.It is possible that the results of this study will support a staged approach to the treatment of first-episode psychosis such that medications with significant side-effects are reserved for cases where safer treatments have not led to full remission and recovery.The study will also provide important information about structural brain changes in psychosis and the contribution of antipsychotic medication to these changes.The results of this randomised controlled trial will enhance available information about the risk and benefits of treatments for psychosis and thus improve the capacity of clinicians to support informed decision-making by consumers about their treatment.
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Newcastle University
OpenAlex ID: W2604653109
